CALCA and prostate neoplasm: It has been published that CGRP has chemotherapy resistance in acute myeloid leukemia (AML) cell lines via the CGRP/CALCRL axis and promotes prostate tumor growth in murine models, possibly via ERKs/STAT3 signaling (65, 66).